Keymed Biosciences Inc. (HKG:2162)
Hong Kong · Delayed Price · Currency is HKD 81.55
+1.95 (2.45%)
Sep 30, 2026, 4:08 PM HKT
Keymed Biosciences Market Cap
Keymed Biosciences has a market cap or net worth of 23.45 billion as of September 29, 2026. Its market cap has increased by 13.23% in one year.
Market Cap
23.45B
Enterprise Value
20.53B
Revenue
963.56M
Ranking
n/a
PE Ratio
25.41
Stock Price
81.55
ChartMarket Cap Chart
Since July 8, 2021, Keymed Biosciences's market cap has increased from 18.43B to 23.45B, an increase of 27.25%. That is a compound annual growth rate of 4.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 23.45B | 48.92% |
| Dec 31, 2025 | 15.75B | 84.90% |
| Dec 31, 2024 | 8.52B | -37.32% |
| Dec 29, 2023 | 13.59B | -4.15% |
| Dec 30, 2022 | 14.17B | 46.87% |
| Dec 31, 2021 | 9.65B | -47.63% |
| Jul 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 3SBio | 39.83B |
| Shanghai Junshi Biosciences | 35.97B |
| InSilico Medicine Cayman TopCo | 32.05B |
| Shanghai Henlius Biotech | 31.19B |
| InnoCare Pharma | 29.94B |
| Zai Lab | 22.00B |
| Metis TechBio | 18.46B |
| Duality Biotherapeutics | 17.80B |